https://doi.org/10.4081/reumatismo.2011.171
Splenic tuberculosis in a patient with ankylosing spondylitis treated with adalimumab
Submitted: 9 November 2011
Accepted: 9 November 2011
Published: 9 November 2011
Accepted: 9 November 2011
Abstract Views: 938
PDF: 722
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Authors
How to Cite
Azevedo, V., Paiva, E., Tosin, T., Ferreira, A., Ferreira, A., & Fernandes, M. (2011). Splenic tuberculosis in a patient with ankylosing spondylitis treated with adalimumab. Reumatismo, 63(3), 171–174. https://doi.org/10.4081/reumatismo.2011.171
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
Similar Articles
- F. Ingegnoli, N. Del Papa, E. Lupi, D.P. Comina, W. Maglione, V. Gerloni, F. Fantini, Anti-chromatin antibodies in juvenile rheumatoid arthritis , Reumatismo: Vol. 55 No. 4 (2003)
- F. Pasqui, L. Mastrodonato, F. Ceccarelli, R. Scrivo, L. Magrini, V. Riccieri, M. Di Franco, M. Gentili, G. Valesini, A. Spadaro, Occupational therapy in rheumatoid arthritis: short term prospective study in patients treated with anti-TNF-alpha drugs , Reumatismo: Vol. 58 No. 3 (2006)
- L. Cavagna, P. Rossi, L. Bogliolo, E. Antoniazzi, C. Gelmi, R. Caporali, C. Montecucco, Early electroretinografic changes in elderly RA patients treated with hydroxychloroquine , Reumatismo: Vol. 54 No. 3 (2002)
- S. Zingarelli, P. Airò, M. Frassi, C. Bazzani, M. Scarsi, M. Puoti, Prophylaxis and therapy of HBV infection in 20 patients treated with disease modifying antirheumatic drugs or with biological agents for rheumatic diseases , Reumatismo: Vol. 60 No. 1 (2008)
- S. Bello, C. Bonali, L. Serafino, P. Di Giuseppe, A. Minosi, N. Terlizzi, Intra-articular therapy with infliximab in psoriatic arthritis: efficacy and safety in refractory monoarthritis , Reumatismo: Vol. 62 No. 1 (2010)
- M. Di Gangi, R. Foti, R. Leonardi, C. Leonetti, P. Castellino, Recurrent new-onset uveitis in a patient with rheumatoid arthritis during anti-TNFα treatment , Reumatismo: Vol. 59 No. 2 (2007)
- A. Laria, A. Zoli, E. Gremese, G.F. Ferraccioli, Proton pump inhibitors in rheumatic diseases: clinical practice, drug interactions, bone fractures and risk of infections , Reumatismo: Vol. 63 No. 1 (2011)
- G. Pasero, P. Marson, A short history of anti-rheumatic therapy - V. Analgesics , Reumatismo: Vol. 63 No. 1 (2011)
- R. Neri, M. Mosca, T. Grazzini, A. Tavoni, G. Pasero, S. Bombardieri, Long term functional outcome of idiopathic inflammatory myopathies , Reumatismo: Vol. 53 No. 1 (2001)
- S. Casigliani Rabl, A. Della Rossa, P. Pepe, A. D'Ascanio, M. Mosca, A. Di Vita, S. Bombardieri, Long-term cyclic intravenous iloprost in systemic sclerosis: clinical experience from a single center , Reumatismo: Vol. 64 No. 3 (2012)
<< < 14 15 16 17 18 19 20 21 22 23 > >>
You may also start an advanced similarity search for this article.
